D5DR Inhibitors

The chemical class of D5DR Inhibitors consists of a diverse group of compounds primarily characterized by their ability to antagonize dopamine receptor activity, either directly or indirectly. These inhibitors interact with the dopaminergic system in various ways. Some, like SCH-23390, are selective and bind directly to D5DR, blocking its activation. Others, such as fluphenazine, haloperidol, and chlorpromazine, are less selective and antagonize multiple dopamine receptor subtypes, including D5DR. The action of these drugs results in decreased dopaminergic signaling, which in turn reduces D5DR activity. Furthermore, some compounds in this class, like domperidone, L-741,626, sulpiride, and amisulpride, are known for their specificity towards D2-like receptors but may indirectly affect D5DR due to the intricate interplay within the dopamine receptor family. The interconnectedness of these receptor subtypes means that antagonizing one subtype can have ripple effects on the function of others, including D5DR.